Preimplantation genetic testing for familial amyloid polyneuropathy
Abstract Background Embryo selection in Familial amyloid polyneuropathy eradicates the disease, but the widespread application of preimplantation genetic testing (PGT) for this monogenic disease still requires greater political and clinical commitment. Main body Familial amyloid polyneuropathy is a...
Main Author: | Mário Sousa |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | Reproductive Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12978-022-01491-x |
Similar Items
-
Transthyretin-Related Familial Amyloid Polyneuropathy: In the Light of New Developments
by: Arman Çakar, et al.
Published: (2017-09-01) -
Utility of Genetic Testing in Patients with Transthyretin Amyloid Cardiomyopathy: A Brief Review
by: Ana-Maria Merino-Merino, et al.
Published: (2023-12-01) -
Familial Amyloid Polyneuropathy Misdiagnosed as Systemic Sclerosis
by: Marcia Agostinho Pereira, et al.
Published: (2022-01-01) -
Updated Evaluation of the Safety, Efficacy and Tolerability of Tafamidis in the Treatment of Hereditary Transthyretin Amyloid Polyneuropathy
by: Falcão de Campos C, et al.
Published: (2023-02-01) -
Vitreous Amyloidosis as the Presenting Symptom of Familial Amyloid Polyneuropathy TTR Val30Met in a Portuguese Patient
by: Mariana Seca, et al.
Published: (2014-03-01)